Showing results (621-630 of 652) with videos related to
Sort By:
Pageof 66
Nature Communications|April 1, 2026
Whole-proteome phage immunoprecipitation sequencing reveals germ cell tumor-specific immunosignatureM Bakri Hammami, Andrew M Knight, Haidara Kherbek, et al.Journal for Immunotherapy of Cancer|November 29, 2016
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinomaBrian I Rini, David F McDermott, Hans Hammers, et al.American Journal of Hematology|March 28, 2019
Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso-occlusive painMarcus A Carden, David C Brousseau, Fahd A Ahmad, et al.Trials|August 16, 2023
Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trialChris A Rees, David C Brousseau, Daniel M Cohen, et al.Human Pathology|June 23, 2024
High-risk human papilloma virus status & outcomes for penile squamous cell carcinoma: A single institution experienceBurak Tekin, Antonio L Cubilla, John C Cheville, et al.Human Pathology|November 18, 2023
Identification of amyloidosis of the urinary tract and prostate: Opportunities for early diagnosis & intervention in systemic diseaseSarwat I Gilani, Surendra Dasari, Burak Tekin, et al.Human Pathology|November 17, 2023
Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinomaBurak Tekin, John C Cheville, Loren Herrera Hernandez, et al.Mayo Clinic Proceedings|June 26, 2022
Renin Production by Juxtaglomerular Cell Tumors and Clear Cell Renal Cell Carcinoma and the Role of Angiotensin Signaling InhibitorsSounak Gupta, Paige Nichols, Christine M Lohse, et al.Human Pathology|April 2, 2021
Assessment of isochromosome 12p and 12p abnormalities in germ cell tumors using fluorescence in situ hybridization, single-nucleotide polymorphism arrays, and next-generation sequencing/mate-pair sequencingC Eric Freitag, William R Sukov, Alan H Bryce, et al.The Journal of Clinical Investigation|February 1, 2019
Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinomaNiraj Shenoy, Tushar D Bhagat, John Cheville, et al.Pageof 66